Relationship between glycated haemoglobin levels and mean glucose levels over time
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: HbA(1c), expressed as the percentage of adult haemoglobin that is glycated, is the most widely used measure of chronic glycaemia. Achieving near-normal HbA(1c) levels has been shown to reduce long-term complications and the HbA(1c) assay is recommended to determine whether treatment is adequate and to guide adjustments. However, daily adjustments of therapy are guided by capillary glucose levels (mmol/l). We determined the relationship between an accurate measure of mean glucose levels over time and the HbA(1c) level, and whether HbA(1c) can be expressed in the same units as self-monitoring results. METHODS: Twenty-two participants with diabetes and three non-diabetic participants were included in this longitudinal observational study. Mean glucose levels were measured by continuous glucose monitoring (CGM), which measures interstitial glucose levels every 5 min, for 12 weeks. Capillary measurements were obtained four times per day to confirm the accuracy of CGM. HbA(1c) was measured at baseline and every 4 weeks. RESULTS: The HbA(1c) results at weeks 8 and 12 correlated strongly (r = 0.90) with the CGM results during the preceding 8 and 12 weeks. A curvilinear (exponential) relationship and a linear regression captured the relationship with similarly high correlations, which allowed transformation of HbA(1c) values to a calculated mean glucose level. CONCLUSIONS AND INTERPRETATION: HbA(1c) correlates closely with a complete measure of average glycaemia over the preceding 8-12 weeks. The translation of HbA(1c) to an average glucose level for reporting and management purposes is feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several studies have demonstrated a close mathematical relationship between the HbA 1c concentration and mean glycemia that should allow expression of HbA 1c as an eAG (341,373,374).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [374]
In the citing paper
“Several studies have demonstrated a close mathematical relationship between HbA 1c concentration and mean glycemia, which should allow the expression of HbA 1c as an estimated average glucose (eAG) concentration (205,(207)(208)(209).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Nathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., & Zinman, B. (2006) · Diabetes Care · doi:10.2337/dc06-9912 · Cited by 1,203 · cited 7×
“The recommended goals for metabolic control of diabetes are based on the HbA1c assay [2, 14, 15], the vast majority of methods now being standardised to the DCCT assay through an international programme [16].”
BackgroundMethodInfluentialSelf-citationStandards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Correlation of Glucose Regulation and Hemoglobin AIcin Diabetes Mellitus
Koenig, R. J., Peterson, C. M., Jones, R. L., Saudek, C., Lehrman, M., & Cerami, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608192950804 · Cited by 1,175
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s106 · Cited by 988
Cited by
Items 101–200 of 531
Lledó‐García, R., Mazer, N. A., & Karlsson, M. O. (2013) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9289-6 · Cited by 36
“The steady-state relationship between HbA1c and the AG, assessed over a suitably long period of stable glycemia, has been previously explored, in several studies [1, 3, 5, 14, 15].”
ResultKahn, R., & Fonseca, V. A. (2008) · Diabetes Care · doi:10.2337/dc08-0878 · Cited by 36
Glycated haemoglobin variations in paediatric type 1 diabetes: the impact of season, gender and age
Hanberger, L., Åkesson, K., & Samuelsson, U. (2013) · Acta Paediatrica · doi:10.1111/apa.12530 · Cited by 38
Asgharzadeh, A., Patel, M., Connock, M. J., Damery, S. L., Ghosh, I., Jordan, M., Freeman, K., Brown, A., Court, R. A., Baldwin, S., et al. (2024) · Health Technology Assessment · doi:10.3310/jypl3536 · Cited by 37
Lin, L., Dekkers, I. A., Huang, L., Tao, Q., Paiman, E. H. M., Bizino, M. B., Jazet, I. M., & Lamb, H. J. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107973 · Cited by 33
Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients With Type 2 Diabetes
Lu, S., Yin, H., Yu, O. H. Y., & Azoulay, L. (2022) · Epidemiology · doi:10.1097/ede.0000000000001486 · Cited by 34
Tu, Y.-Z., Chang, Y.-T., Chiou, H., & Lai, K. (2021) · Journal of Medical Internet Research · doi:10.2196/23227 · Cited by 31
“We believe that as glycated hemoglobin levels typically reflect blood glucose values in the past 8-12 weeks [18], HbA 1c levels in the first month of the partnership would only be minimally affected by the intervention.”
BackgroundDong, P., Lin, H., Huang, K., & Cheng, J. (2019) · Science Advances · doi:10.1126/sciadv.aav0561 · Cited by 33
Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐ d ‐glucitol
Ohigashi, M., Osugi, K., Kusunoki, Y., Washio, K., Matsutani, S., Tsunoda, T., Matsuo, T., Konishi, K., Katsuno, T., Namba, M., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13437 · Cited by 33
Glucose Metabolism in Primary Aldosteronism
Remde, H., Hanslik, G., Rayes, N., & Quinkler, M. O. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565208 · Cited by 33
The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review
Lemmers, R. F. H., van Hoek, M., Lieverse, A. G., Verhoeven, A. J. M., Sijbrands, E. J. G., & Mulder, M. T. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.03.013 · Cited by 32
Valdés, S., Botas, P., Delgado, E., Álvarez, F. V., & Díaz-Cadórniga, F. J. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.002 · Cited by 35
Venkatesan, T., & Pillai, S. S. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00145.x · Cited by 29
Glycated hemoglobin a1c as a modern biochemical marker of glucose regulation
Kojić-Damjanov, S., Djerić, M., & Eremić-Kojić, N. (2014) · Medicinski pregled · doi:10.2298/mpns1410339k · Cited by 28
Hemoglobin A1c as screening for gestational diabetes mellitus in Nordic Caucasian women
Odsæter, I. H., Åsberg, A., Vanky, E., Mørkved, S., Stafne, S. N., Salvesen, K. Å., & Carlsen, S. M. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0168-y · Cited by 32
“Over the last years, hemoglobin A1c (HbA1c), a marker representing the average of plasma glucose level in the last 8–12 weeks [5], has been endorsed as a diagnostic marker for diabetes mellitus in non-pregnant subjects [6].”
BackgroundSingh, V., Nerimetla, R., Yang, M., & Krishnan, S. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00124 · Cited by 28
Association of Genomic Instability with HbA1c levels and Medication in Diabetic Patients
Grindel, A., Brath, H., Nersesyan, A. K., Knasmüller, S., & Wagner, K. (2017) · Scientific Reports · doi:10.1038/srep41985 · Cited by 27
Amaefule, C. E., Sasitharan, A., Kalra, P., Iliodromoti, S., Huda, M. S. B., Rogozińska, E., Zamora, J., & Thangaratinam, S. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000648 · Cited by 31
“The HbA1c test is a measure of glycated haemoglobin which serves as an indicator of glucose control in the prior 2–3 months [8].”
BackgroundMolecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis
Batten, L., Sathyapalan, T., & Palmer, T. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417465 · Cited by 28
“O-GlcNAcylation is a novel PTM that may be responsible for altering critical platelet proteins [7,79].”
BackgroundGeng, J., Zhang, Y., Wang, B., Xie, J., Xu, B., & Ju, L. (2017) · Medicine · doi:10.1097/md.0000000000006784 · Cited by 26
“Glycated hemoglobin (HbA1c), reflecting the average blood glucose level of the past 2 to 3 months, is a wellknown biomarker of long-term glycometabolic control([6]) and is also recommended in the diagnosis of DM since 2010.”
BackgroundTrouiller, P., Podglajen, E., Hulo, S., Richeval, C., Allorge, D., Garat, A., Matran, R., Amouyel, P., Meirhaeghe, A., & Dauchet, L. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108673 · Cited by 26
Lippi, G., & Targher, G. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00684.x · Cited by 26
“Remarkably, the slope of the regression equation relating A1c to MBG obtained in the DirecNet study (18 mg/dL for each 1% change in A1c) was much lower than that found in other studies on adult individuals with both type 1 and type 2 diabetes (32–36 mg/dL) (8, 9).”
ResultOhde, S., Deshpande, G. A., Yokomichi, H., Takahashi, O., Fukui, T., & Yamagata, Z. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.013 · Cited by 27
Glurich, I., Bartkowiak, B., Berg, R. L., & Acharya, A. (2018) · International Dental Journal · doi:10.1111/idj.12405 · Cited by 26
Paes, V. M., Barrett, J., Taylor-Robinson, D. C., Chesters, H., Charalampopoulos, D., Dunger, D. B., Viner, R., & Stephenson, T. J. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12850 · Cited by 29
Modeling continuous glucose monitoring (CGM) data during sleep
Gaynanova, I., Punjabi, N. M., & Crainiceanu, C. M. (2020) · Biostatistics · doi:10.1093/biostatistics/kxaa023 · Cited by 36
Shiferaw, W. S., Akalu, T. Y., Desta, M., Kassie, A. M., Petrucka, P. M., Assefa, H. K., & Aynalem, Y. A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.003 · Cited by 33
Zhou, Q., Lei, X., Fu, S., Li, Z., Chen, Y., Long, C., Li, S., & Chen, Q. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.960580 · Cited by 30
“As the lifespan of an erythrocyte is around 120 days (Shemin and Rittenberg, 1946), HbA1c levels reflect average plasma glucose levels over a minimum of 2–3 months (Nathan et al., 2007).”
BackgroundMeasurement of Hemoglobin A1c from Filter Papers for Population-Based Studies
Egier, D. A., Keys, J. L., Hall, S., & McQueen, M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.156380 · Cited by 31
SCHMITT, A. J., McSharry, J., Speight, J., Holmes‐Truscott, E., Hendrieckx, C., Skinner, T. C., Pouwer, F., & Byrne, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.196 · Cited by 27
Allwright, M., Karrasch, J. F., O'Brien, J. A., Guennewig, B., & Austin, P. J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110725 · Cited by 26
Meme, N., Amwayi, S. A., Nganga, Z., & Buregyeya, E. (2015) · Pan African Medical Journal · doi:10.11604/pamj.2015.22.286.7395 · Cited by 27
“There is also a strong correlation between average plasma glucoseand HbA1C in predicting diabetes development in patients with cardiovascular disease such as hypertension, coronary artery disease and stroke [22-27].”
BackgroundQi, M., McFadden, B., Valiente, L., Omori, K., Bilbao, S., Juan, J., Rawson, J., Oancea, A. R., Scott, S., Nair, I., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x683548 · Cited by 24
Diabetes Prevalence and Risk Factors in Four Asian American Communities
STEWART, S. L., Dang, J. H. T., & Chen, M. S. (2016) · Journal of Community Health · doi:10.1007/s10900-016-0214-6 · Cited by 25
“The HbA1c test is the primary test used for diabetes management and diabetes research and reflects an individual’s average levels of blood glucose over the past 3 months [19].”
MethodAyadurai, S., Hattingh, L., Tee, L. B. G., & Said, S. N. M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5897452 · Cited by 26
Wang, X., Tian, B., Zhang, S., Zhang, J., Yang, W., Li, J., Wang, W., Wang, Y., & Zhang, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-45312-y · Cited by 29
“HbA1c level reflects the average blood glucose concentrations for the preceding 2–3 months in patients 42,43 .”
BackgroundDoes A1c consistently reflect mean plasma glucose?
Shrom, D., Sarwat, S., Ilag, L. L., & Bloomgarden, Z. T. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00066.x · Cited by 23
Elevated glycated hemoglobin level and hyperglycemia after aneurysmal subarachnoid hemorrhage
Beseoglu, K., & Steiger, H. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.10.037 · Cited by 23
Kim, Y. H., Her, A., Jeong, M. H., Kim, B., Hong, S., Kim, S., Ahn, C., Kim, J., Ko, Y., Choi, D., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107994 · Cited by 23
Hemoglobin Glycation Rate Constant in Non-diabetic Individuals
Ładyżyński, P., Wojcicki, J. M., Bak, M. I., Sabalińska, S., Kawiak, J., Foltyński, P., Krzymień, J., & Karnafel, W. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0366-6 · Cited by 23
A Deep Reinforcement Learning Approach for Type 2 Diabetes Mellitus Treatment
Liu, Z., Ji, L., Jiang, X., Zhao, W., Liao, X., Zhao, T., Liu, S., Sun, X., Hu, G., Feng, M., et al. (2020) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi48887.2020.9374313 · Cited by 32
“HbA1c is a result of a medical test detecting blood density of glycated hemoglobin, representing the average blood glucose level over the past 8 to 12 weeks [28].”
BackgroundHsu, Y.-J., Chen, Y., Lin, K., Lee, M., Lee, Y.-L., Yu, C.-K., Kabasawa, Y., & Huang, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168371 · Cited by 26
“HbA1c reflects average glycaemia trends over the previous 8 to 12 weeks [31].”
BackgroundZhou, Y., Zhong, L., Zhong, Y., & Liao, Y. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10179-5 · Cited by 22
Relationship between dry eye and glycosylated haemoglobin among diabetics in Ibadan, Nigeria
Olaniyan, S. I., Fasina, O., Bekibele, C. O., & Ogundipe, A. O. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.33.14.14074 · Cited by 22
Kusunoki, Y., Katsuno, T., Nakae, R., Watanabe, K., Akagami, T., Ochi, F., Tokuda, M., Murai, K., Miuchi, M., Miyagawa, J., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.040 · Cited by 24
“blood glucose fluctuation parameters obtained by SMBG and CGM have been widely investigated [27–29].”
InfluentialŁadyżyński, P., Foltyński, P., Bak, M. I., Sabalińska, S., Krzymień, J., & Kawiak, J. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0328-5 · Cited by 22
“This result confirms the data reported in the clinical studies showing that HbA1c is sensitive to MBG level but not to glycemic short-term variations [2,21-23] because the MBG levels used in these three methods were very similar to each other, whereas the glucose variability measures were significantly different.”
ResultNishimura, R., Osonoi, T., Koike, Y., Miyata, K., & Shimasaki, Y. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01097-z · Cited by 23
“Glycemic control is currently assessed using the most common marker, glycated hemoglobin A1c (HbA1c), which closely correlates with the average plasma glucose level over a preceding 8to 12-week period [4], as well as fasting blood glucose in a clinical setting.”
BackgroundChen, M., Pan, P., Zhang, H., Li, R., Ren, D., & Jiang, B. (2024) · Food & Function · doi:10.1039/d4fo02316a · Cited by 22
Nayak, C., Oberai, P., Varanasi, R., Baig, H. A., Ch, R., Reddy, G. R. C., Devi, P. G., Bhubaneshwari, S., Singh, V., Singh, V., et al. (2013) · Homeopathy · doi:10.1016/j.homp.2013.02.004 · Cited by 21
Addepally, N. S., George, N. E., Martínez-Macías, R. F., García-Saenz-de-Sicilia, M., Kim, W. R., & Duarte‐Rojo, A. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5265-3 · Cited by 23
Advances in HbA1c Biosensor Development Based on Field Effect Transistors: A Review
Ahmadi, A., Kabiri, S., & Omidfar, K. (2020) · IEEE Sensors Journal · doi:10.1109/jsen.2020.2987836 · Cited by 21
“D IABETES mellitus or diabetes is a chronic and lifelong disease that can be appeared by symptoms of remarkable increase in blood glucose level (hyperglycemia) and glucose intolerance resulting from a defect in insulin secretion, insulin action, or both [1]–[3].”
BackgroundA Step Backward—or Is it Forward?
GENUTH, S. M., & Kahn, R. (2008) · Diabetes Care · doi:10.2337/dc07-2407 · Cited by 23
“A similar nomogram with an appropriate baseline and increments can now be constructed for A1C (15), as standardization of the assay has proceeded well (22) and we are deriving accura te and prec i se es t imates o f equivalence between A1C and average glucose levels (23).”
MethodPlasma glucose and hemoglobin A 1c for the detection of diabetes in C hinese adults
Xu, Y., Zhao, W., Wang, W., Bi, Y., Li, J., Mi, S., Xu, M., Lu, J., Wang, T., Li, M., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12305 · Cited by 23
“This could be due to the close correlation between HbA1c and the complete measure of average glucose levels over a prolonged period of time rather than a single point measurement of glucose, which has a large biological variability and is preanalytically unstable.(29,30) A simple and reliable approach to the early det…”
BackgroundSerum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes
Zhuang, L., Su, J., Zhang, X., Huang, H., Zhao, L., Xu, F., Chen, T., Wang, X., Wu, G., & Wang, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162204 · Cited by 24
“HbA1c, which determines the overall glycemic levels by integrating both fasting and postprandial hyperglycemia [25], was not reported to associate with the serum amylase levels [10].”
BackgroundGriffin, T. P., Wall, D., Browne, G. A., Dennedy, M. C., & O’Shea, P. M. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217728964 · Cited by 21
Sergazinov, R., Leroux, A., Cui, E., Crainiceanu, C. M., Aurora, R. N., Punjabi, N. M., & Gaynanova, I. (2023) · Biometrics · doi:10.1111/biom.13878 · Cited by 31
“This makes sense, as HbA 1𝑐 , is thought to measure an average of glucose values over the past 3 months (Nathan et al., 2007).”
BackgroundMøller, J. B., Overgaard, R. V., Kjellsson, M., Kristensen, N. R., Klim, S., Ingwersen, S., & Karlsson, M. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.58 · Cited by 21
Ezenwaka, C. E., Dimgba, A., Okali, F., Teppany, S., Martina, R., Extavour, R. M., Verdine, D., Alida, S., Mayers, H., & Altheia, J. (2011) · PubMed · Cited by 22
HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus
Zhu, B., Bu, L., Zhang, M., Gusdon, A. M., Zheng, L., Rampersad, S., Li, J., & Qu, S. (2016) · Scientific Reports · doi:10.1038/srep39687 · Cited by 22
Glucose Screening Measurements and Noninvasive Glucose Monitor Methods
Zheng, H., He, J., Li, P., Guo, M., Jin, H., Shen, J., Xie, Z., & Chi, C. (2018) · Procedia Computer Science · doi:10.1016/j.procs.2018.10.202 · Cited by 21
“• HbA1c can reflect the average of plasma glucose level over the previous two to three months [25].”
Berbudi, A., Rahmadika, N., Cahyadi, A. I., & Ruslami, R. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2037565 · Cited by 24
“to evaluate blood glucose control over the previous 2–3 months [13, 14], with HbA1c levels higher than 6.”
Capula, C., Mazza, T., Vero, R., & Costante, G. (2013) · PubMed · doi:10.3275/9037 · Cited by 28
de Medeiros, S. F. (2014) · Journal of Clinical Medicine Research · doi:10.14740/jocmr1829w · Cited by 24
Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes
Syreeni, A., Sandholm, N., Cao, J., Toppila, I., Maahs, D. M., Rewers, M., Snell‐Bergeon, J. K., Costacou, T., Orchard, T. J., Caramori, M. L., et al. (2019) · Diabetes · doi:10.2337/db18-0573 · Cited by 20
“HbA1c reflects the glycemic load over ;3 months (7), and traits such as hemoglobinopathies, alterations in intracellular glucose metabolism, or defects of glucose transport into erythrocytes affect HbA1c.”
BackgroundGlucodensity functional profiles outperform traditional continuous glucose monitoring metrics
Matabuena, M., Ghosal, R., Aguilar, J. E., Keshet, A., Wagner, R. J., Fernández‐Merino, C., Castro, J. S., Zipunnikov, V., Onnela, J.-P. “., & Gudé, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-18119-2 · Cited by 20
“The traditional CGM and non-CGM models include: (i) baseline FPG and HbA1c; and (ii) baseline FPG and HbA1c, along with CGM metrics like the Area Under the Curve (AUC), Mean Amplitude of Glycemic Excursions (MAGE), Continuous Overall Net Glycemic Action (CONGA), and hyperglycemia time-in-range.”
Hu, Y., Shen, Y., Yan, R., Li, F.-F., Ding, B., Wang, H., Su, X., & Ma, J. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00879-x · Cited by 22
Glucose-lowering effects of orally administered superoxide dismutase in type 2 diabetic model rats
Guo, J., Liu, H., Zhao, D., Pan, C., Jin, X., Hu, Y., Gao, X., Rao, P., & Liu, S. (2022) · npj Science of Food · doi:10.1038/s41538-022-00151-5 · Cited by 19
Kowsar, R., & Mansouri, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-25813-y · Cited by 19
How Does Diet Change with A Diagnosis of Diabetes? Protocol of the 3D Longitudinal Study
Burch, E., Williams, L. T., Makepeace, H., Alston‐Knox, C., & Ball, L. (2019) · Nutrients · doi:10.3390/nu11010158 · Cited by 20
“HbA1c reflects average plasma glucose over the previous six to eight-week period [48,49].”
BackgroundMarkers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics
Teruya, T., Sunagawa, S., Mori, A., Masuzaki, H., & Yanagida, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-29619-4 · Cited by 18
Huang, H., Wang, B., Peng, Z. W., Liu, S., Zhan, S., Yang, X., Huang, S., Wang, W. T., Zhu, Y. Z., & Xiao, W. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116262 · Cited by 18
Crossover design and its application in late‐phase diabetes studies
Wang, T., Malone, J. K., Fu, H., Heilmann, C. R., Qu, Y., & Huster, W. J. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12412 · Cited by 18
Hansen, U. M., Willaing, I., Ventura, A. D., Olesen, K., Speight, J., & Browne, J. L. (2017) · Patient · doi:10.1007/s40271-017-0289-x · Cited by 18
Kanters, S., Wilkinson, L., Vražić, H., Sharma, R., Lopes, S. H. K., Popoff, E., & Druyts, E. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023458 · Cited by 19
“0% HbA1c, having no hypoglycaemic events and no weight gain) and (4) RCT studies with treatment duration of as low as 20 weeks, including cross-over trials with a minimum 20-week assessment of efficacy outcomes at cross-over, because this was viewed as the amount of time for an antidiabetic to have its full effect on…”
Thornton‐Swan, T. D., Armitage, L. C., Curtis, A. M., & Farmer, A. A. (2021) · Diabetic Medicine · doi:10.1111/dme.14777 · Cited by 22
Hutchinson, M. S., Joakimsen, R. M., Njølstad, I., Schirmer, H., Figenschau, Y., & Jorde, R. (2012) · PubMed · doi:10.3275/8191 · Cited by 24
Glassy Carbon Paste Electrodes for the Determination of Fructosyl Valine
Chien, H., & Chou, T. (2010) · Electroanalysis · doi:10.1002/elan.200900384 · Cited by 18
Glycated haemoglobin; past, present, and future are we ready for the change.
Syed, I. A. A. (2011) · PubMed · Cited by 32
Hemoglobin A1c in Hemodialysis Patients: Should One Size Fit All?
Ix, J. H. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04410510 · Cited by 19
“Other small studies have demonstrated that HbA1c remains correlated with fasting and postchallenge glucose levels in ESRD (21), but the correlations are weaker than those reported in the general population (22,23).”
Miao, L., Shen, X., Du, Z., & Liao, J. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02831-6 · Cited by 19
“This novel index accounts for baseline glucose levels by utilizing HbA1c, reflecting long-term glycemic control unaf - fected by acute exacerbations [11].”
Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal Disease
Kim, J.-K., Park, J. T., Oh, H. J., Yoo, D. E., Kim, S. J., Han, S. H., Kang, S., Choi, K. H., & Yoo, T. (2012) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.3.578 · Cited by 20
“ration of diabetes was 204 (10-600) months.”
Yoshihara, T., Ozaki, H., Nakagata, T., Natsume, T., Kitada, T., Ishihara, Y., Sawada, S., Ishibashi, M., Kobayashi, H., Machida, S., et al. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2480-9 · Cited by 19
Cavero‐Redondo, I., Peleteiro, B., Álvarez‐Bueno, C., Rodríguez‐Artalejo, F., & Martínez‐Vizcaíno, V. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012229 · Cited by 18
“HbA1c level is an indicator of the average blood glucose concentrations over the preceding 2–3 months and is used as a convenient and well-known biomarker in clinical practice.(7) 8 Epidemiological evidence suggests that Strengths and limitations of this study”
MethodChishiki, T., Nagatomo, Y., Saji, M., Takei, M., Goda, A., Kohno, T., Nakano, S., Nishihata, Y., Ikegami, Y., Shiraishi, Y., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.07.041 · Cited by 15
Washirasaksiri, C., Srivanichakorn, W., Borrisut, N., Sitasuwan, T., Tinmanee, R., Kositamongkol, C., Ariyakunaphan, P., Auesomwang, C., Sayabovorn, N., Chaisathaphol, T., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950225 · Cited by 17
“HbA1c represents the average blood glucose level during approximately the preceding 3 months (Nathan et al., 2007b; Syed, 2011) and signifies the risk for diabetes.”
BackgroundMulti-level Analysis of HbA1c in Diagnosis and Prognosis of Diabetic Patients
Mukherjee, S., Ray, S. K., Jadhav, A. A., & Wakode, S. L. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998262501231015051317 · Cited by 22
Nathan, D. M., Herman, W. H., Larkin, M., Krause-Steinrauf, H. J., Assi, H. A., Ahmann, A., Brown-Friday, J., Hsia, D. S., Harindhanavudhi, T., Johnson, M. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-1362 · Cited by 17
Self-citationOgugua, C. F., Chikani, U. N., Okiche, C. Y., & Ibekwe, M. U. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.250.19790 · Cited by 20
Muniz, T. P., Araújo, D. V., Savage, K. J. J., Cheng, T., Saha, M., Song, X., Gill, S., Monzon, J. G., Grenier, D., Genta, S., et al. (2021) · Cancers · doi:10.3390/cancers14010089 · Cited by 16
“Most of our patients presented with overt hyperglycemia and disproportionately low HbA1c levels [34,35].”
Ehrmann, D., Eichinger, V., Vesper, I., Kober, J., Kraus, M., Schäfer, V., Hermanns, N., Kulzer, B., & Silbermann, S. (2022) · Trials · doi:10.1186/s13063-022-06248-2 · Cited by 18
Motor Function Improvement in Patients Undergoing Surgery for Spinal Epidural Abscess
Wang, T., Lu, M., Yang, J., Weng, H., Cheng, Y.-K., Lin, M. H., Su, C.-H., & Lee, M. (2010) · Neurosurgery · doi:10.1227/01.neu.0000368441.10356.28 · Cited by 15
Payk, M., Robinson, T., Davis, D. L., & Atchan, M. (2017) · Journal of Advanced Nursing · doi:10.1111/jan.13463 · Cited by 18
“Self-blood glucose monitoring by people with diabetes identifies the spectrum with which glucose levels vary and this is not replicated in the HbA1c measure (Nathan et al., 2007).”
BackgroundSteady-state relationship between average glucose, HbA1c and RBC lifespan
Kameyama, M., Takeuchi, S., & Ishii, S. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.03.023 · Cited by 15
de Medeiros, S. F., de Medeiros, A. K. L. W. Y., de Medeiros, M. A. S., Carvalho, A. B. D. S., Yamamoto, M. M., Soares, J. M., & Baracat, E. C. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2207-0739 · Cited by 15
“Because glycated hemoglobin (HbA1c) is expressed as a percentage of the amount of hemoglobin with glucose attached over a period of 5–12 weeks, it has been accepted as an adequate method to predict carbohydrate metabolism abnormalities during this time in PCOS [18].”
MethodInfluentialMnatzaganian, G., Lee, C., Cowen, G., Boyd, J., Varhol, R., Randall, S. M., & Robinson, S. (2024) · BMC Medicine · doi:10.1186/s12916-024-03698-0 · Cited by 19
“Similarly, patients diagnosed with diabetes based on abnormal HbA 1c levels within 12 weeks after 395 days from the first patient-GP encounter were regarded as prevalent cases as HbA 1c levels reflect average plasma glucose over the previous 8–12 weeks from the time of the test [29].”
Freckmann, G., & Mende, J. (2018) · Journal of Laboratory Medicine · doi:10.1515/labmed-2018-0119 · Cited by 14
Effect of Covid-19 quarantine on diabetes Care in Children
Gayoso, M., Lim, W. Y., Mulekar, M. S., & Kaulfers, A.-M. D. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00122-x · Cited by 15
“Even though A1c is a typically a 3 month measure, it most closely correlates with the previous 8–12 weeks [4].”
BackgroundPonsanti, K., Ngernyuang, N., Tangnorawich, B., Na‐Bangchang, K., Boonprasert, K., Tasanarong, A., Saeheng, T., Hanwattanakul, A., & Pechyen, C. (2022) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/ac5c0a · Cited by 14
Chan, N. B., Li, W., Aung, T., Bazuaye, E., & Montero, R. (2023) · JMIR AI · doi:10.2196/45450 · Cited by 19
“It is a measure of average glucose within a person over the previous 8 to 12 weeks [9] and has been adopted by major clinical guidelines for managing the glycemic status of patients with T1DM and diagnosing and screening people who are at risk of type 2 DM [10-12].”
MethodMcQueen, R. B., Perez‐Nieves, M., Alonso, G. T., Fan, L., Hankosky, E. R., Shah, V. N., Yan, Y., Ellis, S. L., & Juneja, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111690 · Cited by 14
Metadata
- Authors
- Nathan, D. M., Turgeon, H., & Regan, S.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Nathan, D. M.
- ORCID
- Regan, S.
- Venue
- Diabetologia
- Published
- 2007-09-13
- Volume
- 50
- Issue
- 11
- Pages
- 2239-2244
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC8752566
- OpenAlex
- W2033453118
- Cited by
- 517
- References
- 33
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 28 · 2023: 47 · 2022: 36 · 2021: 34 · 2020: 44 · 2019: 38 · 2018: 24 · 2017: 34 · 2016: 27 · 2015: 30 · 2014: 25 · 2013: 21 · 2012: 14
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Locations
- Diabetologia (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- LifeScan
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- HbA1c, continuous glucose monitoring, capillary blood glucose, diabetes mellitus, glycemic control, exponential relationship, self-monitoring of blood glucose
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Kinetics, Male, Middle Aged, Reference Values, Time Factors, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.